Percutaneous Balloon Aortic Valvuloplasty Revisited

Hara, Hidehiko; Pedersen, Wesley R.; Ladich, Elena; Mooney, M.; Virmani, Renu; Nakamura, Masato; Feldman, Ted; Schwartz, Robert S.

doi:10.1161/circulationaha.106.657098

Cited by 78 publications

(56 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The procedure remains in our armamentarium as a means of temporary symptom relief in the elderly nonsurgical candidate or as a bridge to conventional aortic valve surgery. 7 Aortic valve bypass (apicoaortic conduit) surgery is the construction of a vascular graft containing a bioprosthetic valve from the apex of the left ventricle to the descending thoracic aorta (Figure 2 Durability has been documented with follow-up in some patients in excess of 25 years. 10 The procedure is done without cardioplegia, sternotomy, or crossclamping the aorta and with minimal or no use of cardiopulmonary bypass and thus expands the pool of patients eligible for surgical treatment.…”

Section: Discussionmentioning

confidence: 99%

Heart Failure and “Inoperable” Aortic Stenosis: Staged Balloon Aortic Valvuloplasty and Aortic Valve Bypass

Zimrin

Reyes

Miller

et al. 2008

Congestive Heart Failure

View full text Add to dashboard Cite

The prognosis for patients with symptomatic aortic stenosis is poor but is improved significantly by surgical aortic valve replacement. Unfortunately, many patients are refused surgery because of age, comorbidities, and hemodynamic instability. This report describes the successful use of balloon aortic valvuloplasty as a bridge to aortic valve bypass surgery (apicoaortic conduit) in an elderly patient with class IV congestive heart failure and severe left ventricular systolic dysfunction as a consequence of aortic stenosis who was not a candidate for traditional surgical valve replacement.

show abstract

Section: Discussionmentioning

confidence: 99%

Heart Failure and “Inoperable” Aortic Stenosis: Staged Balloon Aortic Valvuloplasty and Aortic Valve Bypass

Zimrin

Reyes

Miller

et al. 2008

Congestive Heart Failure

View full text Add to dashboard Cite

show abstract

“…The reasons for this are many but are in part related to improvements in BAV techniques; later series have yielded better results than those in the initial registries. 5,6 In the Partner trial, BAV was part of standard medical therapy in 84% of the non-TAVI patients. 7 Other reported uses for BAV are palliation [8][9][10] and bridging to TAVI.…”

Section: Discussionmentioning

confidence: 99%

Contemporary Use of Balloon Aortic Valvuloplasty in the Era of Transcatheter Aortic Valve Implantation

Hui¹,

Shavelle

Cunningham

et al. 2014

Texas Heart Institute Journal

View full text Add to dashboard Cite

The development of transcatheter aortic valve implantation (TAVI) has increased the use of balloon aortic valvuloplasty (BAV) (2009)(2010) and TAVI (2011TAVI ( -2012 P ercutaneous balloon aortic valvuloplasty (BAV) was proposed in 1986 by Alain Cribier as an alternative to surgical aortic valve replacement (SAVR) for treating symptomatic aortic stenosis in high-risk patients.1 Poor long-term results in comparison with SAVR relegated BAV to American College of Cardiology/ American Heart Association class IIB indications in patients who are thought to be inoperable. 2 The transcatheter aortic valve implantation (TAVI) technique uses BAV as an essential procedural step to evaluate annular size, to evaluate displacement of the aortic valve leaflets adjacent to the left main coronary artery, and to facilitate delivering and placing the percutaneous valve. 3 We hypothesized that the introduction of a TAVI program to a cardiac center would influence BAV procedural volumes and indications, not only through its use as an adjunctive step in TAVI, but also in evaluating the severity of aortic stenosis-offering an improvement in left ventricular (LV) dysfunction and thus potentially bridging inoperable patients to TAVI. The purpose of this study was to examine the changing volumes and indications for BAV in a tertiary referral center with a newly developed TAVI program, and to examine the outcomes of patients who had undergone BAV. Patients and MethodsUsing current procedural terminology (CPT) billing codes, we identified consecutive patients who had undergone BAV from January 2009 through December 2012 at our academic tertiary referral center. Comorbidity, clinical, hemodynamic, procedural, and follow-up data were obtained from reviews of hospital records. Data on deaths were obtained from Social Security Death Index records. Study approval was obtained from our institutional review board.

show abstract

“…During subsequent years, application of percutaneous transcatheter aortic valve implantation has evolved rapidly in high risk patients. TAVI, which is being applied in various centers worldwide and the follow-up results of which are reported (around 11 000 patients), can well be applied with a mortality rate of between 6-10%, despite being a high risk intervention (9,10).…”

Section: Diagnosis Of Aortic Valve Stenosis and Indications Of Tavimentioning

confidence: 99%

Transcatheter Aortic Valve Implantation: Our Experience and Review of the Literature

Burgazli¹,

Chasan²,

Kavukçu³

et al. 2012

Balkan Med J

View full text Add to dashboard Cite

Percutaneous Balloon Aortic Valvuloplasty Revisited

Cited by 78 publications

References 17 publications

Heart Failure and “Inoperable” Aortic Stenosis: Staged Balloon Aortic Valvuloplasty and Aortic Valve Bypass

Heart Failure and “Inoperable” Aortic Stenosis: Staged Balloon Aortic Valvuloplasty and Aortic Valve Bypass

Contemporary Use of Balloon Aortic Valvuloplasty in the Era of Transcatheter Aortic Valve Implantation

Transcatheter Aortic Valve Implantation: Our Experience and Review of the Literature

Contact Info

Product

Resources

About